NWNicole Wimmesberger

Nicole Wimmesberger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nicole Wimmesberger has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Group therapy in physiotherapy

    by Marwin Weber, Lea Gorenflo, Lukas Horstmeier, Nicole Wimmesberger, Franziska Killinger, Julia Allekotte, Joerg J. Meerpohl, Sebastian Voigt-Radloff, Angelika Eisele-Metzger

    Group therapy is rarely used in outpatient physiotherapy in Germany, although it is permitted according to the “Heilmittelrichtlinie” and would be preferable to individual therapy if equally suitable. Group therapy could help expand treatment capacities, reduce costs, and promote factors such as motivation and adherence. Whether it is similarly effective to individual therapy for diagnoses that are frequently prescribed, however, remains unclear. To provide an overview of the current evidence on group-based physiotherapy for diagnoses with high prescription rates. An overview of reviews was conducted. A systematic literature search was performed in MEDLINE, CINAHL, EBP, PEDro, OT Seeker, and Google Scholar. Systematic reviews investigating group-based physiotherapy for mobility impairments, back pain, and shoulder lesions were included. Screening and data extraction were conducted according to established standards. The methodological quality of the reviews was assessed using AMSTAR 2. The results were synthesized narratively. Fifteen systematic reviews were included, addressing back pain (n = 7) and mobility impairments (n = 8). No review on shoulder lesions was identified. Some of the reviews reported positive effects of group therapy on functional outcomes and pain compared to no treatment or usual care. Compared to individual therapy, no consistent evidence of superiority or inferiority was found. No direct negative effects of group therapy were reported. The interventions and control groups in the included reviews were mostly heterogeneous. The methodological quality of most reviews is low or critically low. Existing evidence on the effectiveness of group-based physiotherapy is limited and heterogeneous. Most included reviews are of low methodological quality; therefore, no reliable conclusions regarding the effectiveness of group therapy can be drawn. In light of current requirements of the Heilmittelrichtlinie and the high relevance for healthcare provision, there is a need for methodologically rigorous and focused systematic reviews on this topic. If these continue to reveal relevant gaps in the evidence, appropriate clinical studies should be initiated.

  • Wissenstransferstrategien, Forschungserfahrungen und -bedarfe in medizinischen Rehabilitationseinrichtungen

    by Nicole Wimmesberger, Urs Fichtner, Erik Farin

    Zusammenfassung: Hintergrund Um Forschungsergebnisse effektiv in der Gesundheitsversorgung anzuwenden, müssen sie verständlich und leicht zugänglich für alle Beteiligten präsentiert werden. Die REHA-KNOWS Studie in Südwestdeutschland untersucht bestehende Wissenstransferstrategien in medizinischen Rehabilitationszentren, identifiziert Verbesserungsmöglichkeiten und erkundet die Forschungserfahrungen sowie -bedarfe der Praxisvertreter:innen in diesem Bereich, um zur Schließung der Wissens-Praxis-Lücke beizutragen. Material und Methoden Für die Querschnittsbefragung wurde ein standardisierter Online-Fragebogen an Repräsentant:innen von Rehabilitationseinrichtungen in Baden-Württemberg und im Saarland verschickt. Der Fragebogen beinhaltet Fragen zu Teilnehmer:innen, Einrichtungen, aktuellen und vergangenen Forschungsaktivitäten, Forschungsbedarfen und Wissenstransferstrategien. Die Daten wurden deskriptiv analysiert und inhaltsanalytisch aufbereitet. Ergebnisse Innerbetriebliche (76,1%) und externe (76,1%) Fort- und Weiterbildungen sowie wissenschaftliche Fachzeitschriften (72,7%) sind die am häufigsten genutzten Wissenstransferstrategien. Die überwiegende Mehrzahl der Befragten (63,3%) sieht konkretes Verbesserungspotential bei der Integration wissenschaftlicher Ergebnisse in ihren Arbeitsalltag. 55,7% der Befragten hat an mindestens einem Forschungsprojekt teilgenommen, während sich fast ein Viertel (22,7%) noch nie an einem Forschungsprojekt beteiligt hatte. Besonderen Forschungsbedarf sehen die Teilnehmenden in den Themen „Assessmentinstrumente“ (59,1%), „Einflussfaktoren, die das Reha-Ergebnis beeinflussen“ (56,8%) und „Evaluation von Therapieformen und -programmen“ (54,6%). Schlussfolgerungen Viele Vertreter:innen aus Rehabilitationseinrichtungen sind an Forschungsprojekten beteiligt, sehen einen Forschungsbedarf zu Assessmentinstrumenten und nutzen interne sowie externe Fort- & Weiterbildungen als Wissenstransferstrategie. Die Ergebnisse können als Grundlage für eine zukünftige, zielgerichtetere rehabilitationswissenschaftliche Forschung und Praxis dienen.

  • Open Access

    Correction: Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial

    by Nicole Wimmesberger, Diana Rau, Florian Schuchardt, Simone Meier, Matthias L Herrmann, Ulrike Bergmann, Erik Farin-Glattacker, Jochen Brich

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be


  • Open Access

    Correction: Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial (Preprint)

    by Nicole Wimmesberger, Diana Rau, Florian Schuchardt, Simone Meier, Matthias L Herrmann, Ulrike Bergmann, Erik Farin-Glattacker, Jochen Brich

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

  • Open Access

    Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial

    by Nicole Wimmesberger, Diana Rau, Florian Schuchardt, Simone Meier, Matthias L Herrmann, Ulrike Bergmann, Erik Farin-Glattacker, Jochen Brich

    Background: Endovascular thrombectomy (ET), combined with intravenous thrombolysis if possible, is an effective treatment option for patients with stroke who have confirmed anterior large vessel occlusion (aLVO). However, ET is mainly limited to comprehensive stroke centers (CSCs), resulting in a lack of ET capacity in remote, sparsely populated areas. Most stroke networks use the “Drip and Ship” or “Mothership” strategy, resulting in either delayed ET or intravenous thrombolysis, respectively. Objective: This study protocol introduces the Leitstellen-Basierte Erkennung von Schlaganfall-Patienten für eine Thrombektomie und daraufhin abgestimmte Optimierung der Rettungskette (LESTOR) strategy, developed to optimize the preclinical part of the stroke chain of survival to improve the clinical outcome of patients with suspected aLVO stroke. This involves refining the dispatch strategy for identifying patients with acute aLVO stroke using a phone-based aLVO query. This includes dispatching emergency physicians and emergency medical services (EMS) to urban emergency sites, as well as dispatching helicopter EMS to remote areas. If a highly suspected aLVO is identified after a standardized aLVO score evaluation during a structured examination at the emergency scene, prompt transport to a CSC should be prioritized. Methods: The LESTOR study is a controlled, nonrandomized study implementing the LESTOR strategy, with a stepped-wedge, cluster trial design in 6 districts in southwest Germany. In an interprofessional, iterative approach, an aLVO query or dispatch protocol intended for use by dispatchers, followed by a coordinated aLVO examination score for use by EMS, is being developed, evaluated, and pretested in a simulation study. After the training of all participating health care professionals with the corresponding final aLVO query, the LESTOR strategy is being implemented stepwise. Patients otherwise receive usual stroke care in both the control and intervention groups. The primary outcome is the modified Rankin Scale at 90 days in patients with stroke receiving endovascular treatment. We will use a generalized linear mixed model for data analysis. This study is accompanied by a cost-effectiveness analysis and a qualitative process evaluation. Results: This paper describes and discusses the protocol for this controlled, nonrandomized LESTOR study. Enrollment was completed in June 2023. Data analysis is ongoing and the first results are expected to be submitted for publication in 2024. The project started in April 2020 and will end in February 2024. Conclusions: We expect that the intervention will improve the clinical outcome of patients with aLVO stroke, especially outside the catchment areas of CSCs. The results of the accompanying process evaluation and the cost-effectiveness analysis will provide further insights into the implementation process and allow for a better interpretation of the results. Trial Registration: German Clinical Trials Register DRKS00022152; https://drks.de/search/de/trial/DRKS00022152 International Registered Report Identifier (IRRID): DERR1-10.2196/51683


  • Forschungspartner*innen in der Versorgungsforschung: Bedarf, Akzeptanz und Umsetzbarkeit von vorbereitenden Schulungen

    by Nicole Wimmesberger, Thomas Bierbaum, Laura Keßler, Anna Levke Brütt, Erik Farin-Glattacker

    Zusammenfassung: ZielZiel der dargestellten Online-Umfrage ist die Erfassung des Bedarfs, der Akzeptanz und der praktischen Umsetzbarkeit einer Schulung zum Thema Forschungspartner*in in der Versorgungsforschung, die sich an interessierte Patient*innen und Betroffene richtet. Methode Die Umfrage wurde Ende Januar 2023 über Mitglieder des Patient*innenbeirats des Deutschen Netzwerks für Versorgungsforschung (DNVF) bundesweit an Patient*innen-Verbände und -Gruppen versendet. Die Umfrage besteht aus geschlossenen und offenen Fragen. Die Angaben der Teilnehmenden (n=125) wurden deskriptiv und inhaltsanalytisch in Anlehnung an Kuckartz und Rädiker (2022) ausgewertet. Ergebnisse Die Mehrheit (90,4%) der Befragten findet die Einbeziehung von Patient*innen und der Öffentlichkeit in die Planung und Umsetzung wissenschaftlicher Studien sehr bis äußerst wichtig. Dass mehr als 10% (bzw. mehr als 25%) der Patient*innen bereit wären, an einer kostenfreien Schulung teilzunehmen und als Forschungspartner*in zur Verfügung zu stehen, geben 41,5% (bzw. 17,9%) der Teilnehmenden an. Mehr als Dreiviertel (76,8%) der Befragten halten solche Schulungen für sehr bis äußerst wichtig. Bevorzugte Formate der Teilnehmenden sind schriftliches Informationsmaterial (57,3%), kurze Online-Schulungen (56,5%) sowie kurze, digitale Informationsveranstaltungen (53,2%). Häufig genannte Hindernisse für die Umsetzung einer Schulung sind Reisekosten (60,0%), Zeitaufwand (53,3%) sowie die Notwendigkeit umfangreicher Vorinformationen (48,3%). Die Vorschläge der Teilnehmenden für eine erfolgreiche Durchführung einer Schulung beziehen sich u. a. auf die Verständlichkeit der Fortbildung und die Organisation (Ort, Dauer und Format). Schlussfolgerung Die vorliegenden Ergebnisse zeigen neben einem hohen Bedarf an einer Schulung für Forschungspartner*innen, auch einige Hürden auf. Eine kompakte, verständliche und digitale Informationsveranstaltung mit schriftlichem Informationsmaterial erhöht die Akzeptanz. Damit die praktische Umsetzung gelingt, werden die vorliegenden Ergebnisse in die zu entwickelnde Schulung einfließen.


  • Open Access

    Determinants of implementing the ID ROLL OUT study's interventions: qualitative results

    by N Wimmesberger, R Allen, G Först, G Fink, R Giesen, W V Kern, S Rieg, E Farin-Glattacker

    Issue: Antimicrobial stewardship programmes (ASP) and infectious disease (ID) specialists aim to ensure the rational use of antimicrobials and to improve patient outcomes. Whilst ASPs are established to varying degrees, ID specialists are rarely available in secondary and tertiary care hospitals in Germany. Description of the problem: With the ID ROLL OUT study, we implemented and evaluated an intervention, which comprises ASP with and without ID specialists’ consultation in ten hospitals (excl. university hospitals) in south-west Germany. Little has been reported on the medical and pharmaceutical staff's perspectives on the implementations. This study describes barriers, facilitators, and suggestions for improvement to successfully establish a large-scale multicentre intervention. The participants responsible for implementing the intervention were interviewed using semi-structured, guided interviews at two time-points (t1: n = 17; t2: n = 18). The recorded interviews were analysed for content, following Kuckartz. Results: A high level of acceptance and a positive attitude towards the intervention are conducive to the intervention's successful implementation. The teams find extra time for the study and a close staff collaboration at a local team level to be helpful. The main barriers identified are a high workload, lack of acceptance by colleagues in key roles, and the Covid-19 pandemic. Lack of digitalisation and entrenched internal structures were identified as major barriers. To further improve implementation, more infectious disease training should be provided, along with support from superiors and extension of the intervention phase. Moreover, government-mandated ASP guidelines and quality management by the German Medical Association are desired and expected to contribute in the future. Lessons: The identified determinants provide much-needed key information, which is important for the efficient, targeted and successful implementation of future similar interventions. Key messages: • Acceptance, positive attitude and staff collaboration help to implement the intervention. • Heavy workloads and lack of support from key colleagues hinder the intervention’s implementation.

  • Open Access

    Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial (Preprint)

    by Nicole Wimmesberger, Diana Rau, Florian Schuchardt, Simone Meier, Matthias L Herrmann, Ulrike Bergmann, Erik Farin-Glattacker, Jochen Brich

    BACKGROUND Endovascular thrombectomy (ET), combined with intravenous thrombolysis if possible, is an effective treatment option for patients with stroke who have confirmed anterior large vessel occlusion (aLVO). However, ET is mainly limited to comprehensive stroke centers (CSCs), resulting in a lack of ET capacity in remote, sparsely populated areas. Most stroke networks use the “Drip and Ship” or “Mothership” strategy, resulting in either delayed ET or intravenous thrombolysis, respectively. OBJECTIVE This study protocol introduces the Leitstellen-Basierte Erkennung von Schlaganfall-Patienten für eine Thrombektomie und daraufhin abgestimmte Optimierung der Rettungskette (LESTOR) strategy, developed to optimize the preclinical part of the stroke chain of survival to improve the clinical outcome of patients with suspected aLVO stroke. This involves refining the dispatch strategy for identifying patients with acute aLVO stroke using a phone-based aLVO query. This includes dispatching emergency physicians and emergency medical services (EMS) to urban emergency sites, as well as dispatching helicopter EMS to remote areas. If a highly suspected aLVO is identified after a standardized aLVO score evaluation during a structured examination at the emergency scene, prompt transport to a CSC should be prioritized. METHODS The LESTOR study is a controlled, nonrandomized study implementing the LESTOR strategy, with a stepped-wedge, cluster trial design in 6 districts in southwest Germany. In an interprofessional, iterative approach, an aLVO query or dispatch protocol intended for use by dispatchers, followed by a coordinated aLVO examination score for use by EMS, is being developed, evaluated, and pretested in a simulation study. After the training of all participating health care professionals with the corresponding final aLVO query, the LESTOR strategy is being implemented stepwise. Patients otherwise receive usual stroke care in both the control and intervention groups. The primary outcome is the modified Rankin Scale at 90 days in patients with stroke receiving endovascular treatment. We will use a generalized linear mixed model for data analysis. This study is accompanied by a cost-effectiveness analysis and a qualitative process evaluation. RESULTS This paper describes and discusses the protocol for this controlled, nonrandomized LESTOR study. Enrollment was completed in June 2023. Data analysis is ongoing and the first results are expected to be submitted for publication in 2024. The project started in April 2020 and will end in February 2024. CONCLUSIONS We expect that the intervention will improve the clinical outcome of patients with aLVO stroke, especially outside the catchment areas of CSCs. The results of the accompanying process evaluation and the cost-effectiveness analysis will provide further insights into the implementation process and allow for a better interpretation of the results. CLINICALTRIAL German Clinical Trials Register DRKS00022152; https://drks.de/search/de/trial/DRKS00022152 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/51683